Page 74 - MemoriaESP-Eng

RESEARCH GROUPS

á
í

ñ

í

áí
ñí
ó

í
PROGRAMME:
Grupo de Investigación sobre enfermedades
Communic. Disease Surveillance,
transmisibles en una gran ciudad
Prevention and Control
é
í

Group Members
Lead Researcher

STAFF MEMBERS
Cayla Buqueras, Joan Artur

Casals Toquero, Mart
Jacques Avi, Constanza
Contact:
Solano Silveira, Rubn
Servicio de Epidemiología
Agencia de Salud Pública de Barcelona ASSOCIATED MEMBERS

Pl Lesseps 1. 08023 Barcelona. Phone: (+34) 93 238 45 55 De Benito Langa, Javier
E.mail: [email protected] · Website: www.uitb.cat
Garca de Olalla Rizo, Patricia

Martn Snchez, Vicente
Millet Vilanova, Joan Pau

Moreno Martnez, Antonio Main lines of research
Orcau Palau, Angels

Paella Noguera, Helena • Application of the new technologies to tuberculosis (TB) control: See the web
page of the “TB Investigation Unit of Barcelona” (UITB): http://www.uitb.cat.
Rius Gibert, Cristina
Rodrigo Sanz, Mara Teresa The main objective of UITB is to produce scientific knowledge of relevance on the
control, diagnosis, treatment and prevention of TB. Adherence to treatments and
Snchez Martnez, Francisca
contact tracing are the priorities.
CONTRIBUTORS
• Community health workers’ (CHW) role in the control of communicable diseases:
Asensio, Joan With the massive immigration observed since 2000, we incorporated CHW in the
Serrano, Carmen
prevention and control of infectious diseases. They act as a cultural mediators
and as a translators.

• Studies about the increasing incidence of mumps, pertussis and sexually trans-

mitted infections.
• Epidemic outbreaks.

• International Research:

- Clinical trials for TB: Our centre, which is the only such centre in Europe, is part

of a network of international centres associated with the CDCs TB Trials Consor- 13
tium, promoting international involvement in laying the therapeutic and strategic 20
T
bases for the treatment of active and latent TB infection (LTBI). (See: “Sterling R
TR, et al. N Engl J Med. 2011). This paper has changed the treatment of LTBI. Now PO
E
the recommendation is 3 months once weekly with rifapentine plus isoniazide.
L R
- Investigate the transmission of hepatitis B in autochthonous and immigrant A
NU
populations: with several European groups with a grant from Executive Agency N
for Health and Consumers (Projecte Hepscreen. Screening for hepatitis B and C A
/
among migrants in the European Union).
SP
RE
• Translational Investigation: Significant international diffusion has been achieved E
with our web page. According to Google Analytics, every year we had 10.000- IB
C
20.000 visits, most of them from Spain and Latin America. From the visits and
74
discussion forum comments, it is clear that we continue to play a key role in

Spain and in Latin America.